-
Product Name
Indications
-
Ticagrelor
For patients with acute coronary syndromes (unstable angina, non-ST-segment elevation myocardial infarction or ST-segment elevation myocardial infarction), including those treated with medications or with percutaneous coronary intervention (PCI), to reduce the incidence of thrombotic cardiovascular events
Apply for CEP
Submit DMF to FDA
Pass ISO9001:2005 certification
(For export only)
Pass the inspection of APIs exported to EU
Pass GMP (2010) compliance site inspection
-
Oxiracetam
For the treatment of mild to moderate vascular dementia, Alzheimer’s disease (senile dementia), brain trauma and the resulting neurological function loss, allomnesia and limb dysfunction.
Pass ISO9001:2005 certification
Pass GMP (2010) compliance site inspection
-
L-carnitine
For the prevention and treatment of L-carnitine deficiency, such as L-carnitine deficiency in patients with chronic renal failure due to hemodialysis; and for improving myocardial ischemia, treating angina and other clinical manifestations such as cardiomyopathy, skeletal myopathy (pain), arrhythmia, hyperlipidemia, as well as hypotension and myospasm in dialysis.
Pass ISO9001:2005 certification
(For export only) Apply for CEP
Submit DMF to FDA
-
Ticagrelor intermediate
——
Submit DMF to FDA
Pass ISO9001:2005 certification